Large-Scale Validation of a Flow Cytometry Platform for Comprehensive Immunophenotyping, Cell Size Determination, and Prognostic Stratification in Canine Lymphomas
Boosting the power of AI-based treatment outcome predictions for canine lymphoma by combining tumor and germline genetic biomarkers and live-cell analytics